HS-10375

HS-10375 · Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10375, covering 2024-11-04 to 2024-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) [Phase 1, Phase 2]

See pricing